Company Valuation: Novartis AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 196,458 194,448 207,167 195,514 266,003 305,452 - -
Change - -1.02% 6.54% -5.62% 36.05% 14.83% - -
Enterprise Value (EV) 1 204,649 203,482 219,178 213,458 289,870 339,006 333,796 327,487
Change - -0.57% 7.71% -2.61% 35.8% 16.95% -1.54% -1.89%
P/E 8.2x 28.3x 14.1x 16.5x 19.2x 24.4x 19.1x 16.9x
PBR 2.9x 3.23x 4.41x 4.52x 5.73x 6.95x 6.34x 5.66x
PEG - -0.4x 0x -1x 0.9x -3.01x 0.7x 1.3x
Capitalization / Revenue 3.81x 3.85x 4.44x 3.78x 4.69x 5.29x 4.95x 4.67x
EV / Revenue 3.96x 4.03x 4.7x 4.13x 5.11x 5.87x 5.41x 5x
EV / EBITDA 11.2x 10.9x 12.2x 10.2x 12.4x 14.3x 13x 12x
EV / EBIT 12.3x 12.2x 13.4x 10.9x 13.2x 15.1x 13.9x 12.7x
EV / FCF 15.4x 17x 16.6x 13.1x 16.5x 22.3x 18.3x 16.4x
FCF Yield 6.49% 5.87% 6.01% 7.61% 6.07% 4.48% 5.46% 6.09%
Dividend per Share 2 3.36 3.5 3.823 3.856 4.762 4.372 4.591 4.764
Rate of return 3.83% 3.87% 3.79% 3.94% 3.44% 2.7% 2.84% 2.95%
EPS 2 10.71 3.19 7.15 5.92 7.21 6.625 8.476 9.554
Distribution rate 31.4% 110% 53.5% 65.1% 66% 66% 54.2% 49.9%
Net sales 1 51,626 50,545 46,660 51,722 56,674 57,754 61,699 65,452
EBITDA 1 18,246 18,613 17,937 21,006 23,415 23,745 25,608 27,365
EBIT 1 16,588 16,665 16,372 19,494 21,889 22,385 24,024 25,843
Net income 1 24,021 6,955 14,854 11,939 13,967 12,747 15,683 17,433
Net Debt 1 8,191 9,034 12,011 17,944 23,867 33,554 28,343 22,035
Reference price 2 87.82 90.40 100.79 97.79 138.63 161.73 161.73 161.73
Nbr of stocks (in thousands) 2,237,092 2,150,980 2,055,460 1,999,270 1,918,792 1,888,624 - -
Announcement Date 02/02/22 01/02/23 31/01/24 31/01/25 04/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
24x5.82x14.17x2.73% 305B
42.25x14.3x30.31x0.47% 1,275B
41.82x7.01x19.73x1.87% 680B
37.62x8.63x17.81x2.34% 521B
21.75x5.27x13.2x2.48% 389B
104.88x5.98x25.49x2.3% 356B
24.25x4.85x13.63x1.8% 287B
24.04x7.38x13.56x2.17% 250B
-39.41x7.29x45.94x1.97% 208B
12.07x4.33x8.9x4.08% 185B
Average 29.33x 7.09x 20.27x 2.22% 446B
Weighted average by Cap. 36.36x 8.75x 22.08x 1.78%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Novartis AG

Historical PBR trend

Valuation ratios - PBR - Novartis AG

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Novartis AG

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Novartis AG


Year-on-year evolution of the Yield

Valuation ratios - Yield - Novartis AG
  1. Stock Market
  2. Stocks
  3. NOVN Stock
  4. Valuation Novartis AG